Global Immunoassay For Neurological Biomarkers Market Size & Outlook
Global immunoassay for neurological biomarkers market, 2018-2030 (US$M)
Related Markets
Global immunoassay for neurological biomarkers market highlights
- The global immunoassay for neurological biomarkers market generated a revenue of USD 8,047.3 million in 2023 and is expected to reach USD 18,752.8 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 12.8% by 2030.
- In terms of segment, alzheimer's disease accounted for a revenue of USD 2,887.8 million in 2023.
- Alzheimer's Disease is the most lucrative application segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 8,047.3 million |
| Market revenue in 2030 | USD 18,752.8 million |
| Growth rate | 12.8% (CAGR from 2023 to 2030) |
| Largest segment | Alzheimer's disease |
| Fastest growing segment | Alzheimer's Disease |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Autism Spectrum Disorder |
Other key industry trends
- In terms of revenue, the North America accounted for 41.5% of the global immunoassay for neurological biomarkers market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Italy is the fastest growing regional market and is projected to reach USD 525.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay For Neurological Biomarkers Market Scope
Immunoassay For Neurological Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global immunoassay for neurological biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay for neurological biomarkers market will help companies and investors design strategic landscapes.
Alzheimer's disease was the largest segment with a revenue share of 35.89% in 2023. Horizon Databook has segmented the Global immunoassay for neurological biomarkers market based on alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Immunoassay For Neurological Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Autism Spectrum Disorder
- Others
- Global Immunoassay For Neurological Biomarkers Type Outlook (Revenue, USD Million, 2018-2030)
- Genomic
- Proteomic
- Metabolomic
- Imaging
- Others
- Global Immunoassay For Neurological Biomarkers End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospital & Hospital Laboratories
- Independent clinical diagnostic centers
- Others
Reasons to subscribe to Global immunoassay for neurological biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global immunoassay for neurological biomarkers market databook
-
Our clientele includes a mix of immunoassay for neurological biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global immunoassay for neurological biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global immunoassay for neurological biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global immunoassay for neurological biomarkers market size, by regions, 2018-2030 (US$M)
Top 10 countries: Immunoassay for neurological biomarkers market size, 2023 (US$M)
Global immunoassay for neurological biomarkers market share, by application, 2023 & 2030 (%, US$M)
Immunoassay for neurological biomarkers market: Opportunity assessment by country
Global immunoassay for neurological biomarkers market, by region, 2023 (US$M)
| Application | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2,306.5 | 2,592.0 | 2,367.0 | 2,653.8 | 2,977.7 | 3,343.5 | 3,757.1 | 4,224.9 | 4,754.6 | 5,354.7 | 6,035.0 | 6,806.8 | 7,683.0 | 12.6% |
| Europe | 1,563.9 | 1,759.2 | 1,608.1 | 1,804.8 | 2,027.1 | 2,278.4 | 2,562.9 | 2,885.0 | 3,250.0 | 3,663.9 | 4,133.6 | 4,667.1 | 5,273.3 | 12.7% |
| Asia Pacific | 1,017.8 | 1,157.2 | 1,069.0 | 1,212.3 | 1,375.8 | 1,562.3 | 1,775.3 | 2,018.7 | 2,297.0 | 2,615.4 | 2,979.9 | 3,397.5 | 3,876.2 | 13.9% |
| Latin America | 298.1 | 333.7 | 303.5 | 338.9 | 378.7 | 423.4 | 473.8 | 530.6 | 594.6 | 666.8 | 748.2 | 840.3 | 944.3 | 12.1% |
| MEA | 310.5 | 347.3 | 315.7 | 352.3 | 393.4 | 439.7 | 491.7 | 550.2 | 616.2 | 690.6 | 774.4 | 869.1 | 976.0 | 12.1% |
| Overall | 5,496.8 | 6,189.4 | 5,663.3 | 6,362.1 | 7,152.6 | 8,047.3 | 9,060.7 | 10,209.4 | 11,512.3 | 12,991.3 | 14,671.2 | 16,580.7 | 18,752.8 | 12.9% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
